Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $228.48 | 9 | 75.3% |
| Education | $75.03 | 3 | 24.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $145.99 | 6 | $0 (2017) |
| Genentech USA, Inc. | $50.00 | 1 | $0 (2017) |
| Genentech, Inc. | $47.95 | 1 | $0 (2020) |
| Bio Products Laboratory USA, Inc. | $33.04 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $13.56 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $12.97 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.86 | 1 | Bio Products Laboratory USA, Inc. ($13.86) |
| 2022 | $32.74 | 2 | Bio Products Laboratory USA, Inc. ($19.18) |
| 2021 | $12.97 | 1 | Horizon Therapeutics plc ($12.97) |
| 2020 | $47.95 | 1 | Genentech, Inc. ($47.95) |
| 2017 | $195.99 | 7 | GlaxoSmithKline, LLC. ($145.99) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2023 | Bio Products Laboratory USA, Inc. | Gammaplex (Drug), Coagadex | Food and Beverage | Cash or cash equivalent | $13.86 | General |
| Category: IVIG | ||||||
| 04/14/2022 | Bio Products Laboratory USA, Inc. | Gammaplex (Drug) | Food and Beverage | Cash or cash equivalent | $19.18 | General |
| Category: IVIG | ||||||
| 03/03/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Respiratory | ||||||
| 02/18/2021 | Horizon Therapeutics plc | ACTIMMUNE (Drug) | Education | In-kind items and services | $12.97 | General |
| Category: ACTIMMUNE | ||||||
| 12/10/2020 | Genentech, Inc. | Xolair (Biological) | Education | In-kind items and services | $47.95 | General |
| Category: Immunology | ||||||
| 11/08/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $123.04 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2017 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $2.49 | General |
| 07/28/2017 | GlaxoSmithKline, LLC. | — | Education | In-kind items and services | $14.11 | General |
| 07/14/2017 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $1.81 | General |
| 04/13/2017 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Immunology | ||||||
| 04/07/2017 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $2.66 | General |
| 02/21/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 334 | 3,591 | $138,348 | $38,650 |
| 2022 | 8 | 316 | 3,556 | $135,471 | $40,911 |
| 2021 | 9 | 379 | 3,606 | $138,523 | $42,480 |
| 2020 | 10 | 369 | 3,933 | $140,192 | $41,830 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 46 | 1,400 | $53,200 | $15,061 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 132 | $27,588 | $7,669 | 27.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 40 | 1,782 | $17,820 | $4,958 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 54 | $15,876 | $4,639 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $11,094 | $3,181 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,376 | $1,401 | 26.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 12 | 123 | $3,567 | $1,002 | 28.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 40 | 43 | $3,827 | $739.85 | 19.3% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 43 | 1,550 | $56,410 | $18,061 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 73 | $18,564 | $6,069 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 107 | $20,085 | $6,024 | 30.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 33 | 1,561 | $18,734 | $4,724 | 25.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $6,180 | $2,060 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,056 | $1,729 | 28.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 12 | 171 | $5,173 | $1,326 | 25.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 48 | 51 | $4,269 | $918.51 | 21.5% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 43 | 1,496 | $52,360 | $17,062 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 113 | 139 | $24,325 | $7,848 | 32.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 55 | $12,375 | $5,286 | 42.7% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 41 | 1,528 | $21,392 | $4,594 | 21.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $7,200 | $2,249 | 31.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $7,800 | $2,149 | 27.6% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 19 | 193 | $5,983 | $1,489 | 24.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 58 | 67 | $5,360 | $1,363 | 25.4% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 12 | 72 | $1,728 | $441.00 | 25.5% |
About Dr. Mark Bubak, MD
Dr. Mark Bubak, MD is a Allergy & Immunology healthcare provider based in Sioux Falls, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336196724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Bubak, MD has received a total of $303.51 in payments from pharmaceutical and medical device companies, with $13.86 received in 2023. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($228.48).
As a Medicare-enrolled provider, Bubak has provided services to 1,398 Medicare beneficiaries, totaling 14,686 services with total Medicare billing of $163,871. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Sioux Falls, SD
- Active Since 05/30/2006
- Last Updated 02/21/2013
- Taxonomy Code 207RA0201X
- Entity Type Individual
- NPI Number 1336196724
Products in Payments
- NUCALA (Biological) $124.92
- Xolair (Biological) $97.95
- Gammaplex (Drug) $33.04
- TEZSPIRE (Biological) $13.56
- ACTIMMUNE (Drug) $12.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.